SCCA Clinical Trials | Breast Cancer | NCT01355393
Links shared publicly online about this topic.
- 115total visits
SCCA Clinical Trials | Breast Cancer | NCT01355393
View full resource at seattlecca.org
Tags: Vaccination, Cancer, Breast Cancer, Disease and Condition, Clinical Trial, Women's Health, Doctor
Most Recently Shared on July 27, 2011 at 8:29 pm By:
RT @seattlecca: Enrolling patients study HER2/neu breast cancer vaccination w/ Ampligen®. http://ow.ly/5KqOL UW/ @SeattleCCA 's Lupe Salazar
SCCA Clinical Trials | Breast Cancer | NCT00684983
seattlecca.org — “Randomized Phase II Trial of Capecitabine and Lapatinib With or Without IMC-A12 in Patients With HER2 Positive Breast Cancer Previously Treated With Trastuzumab and an Anthracycline and/or a Taxane Seattle Cancer Care Alliance is a nationally recognized treatment center that provides advanced therapies and clinical trials for cancers and other blood disorders. SCCA unites the doctors and technology from Fred Hutchinson Cancer Research Center, UW Medicine, and Seattle Children's.” View full resource at seattlecca.org
Most Recently Shared on May 17, 2011 at 11:00 pm By:
Hutchinson Center Hospital and Research
RT @seattlecca: Phase II clinical study just open and recruiting for patients with HER2-positive breast cancer. http://bit.ly/jHInnb
Advertisement
